The 21st Century Cures Act seeks to increase FDA’s funding, free up the agency to focus its efforts on high-risk devices, and fast-track technologies that treat or diagnose the most serious diseases or conditions.
News & Features
Giovanni Colella Giovanni Colella is CEO of CastLight Health, which is literally shining light into black box - healthcare pricing.
Advances in sensor technology and data analytics are coming together to put unprecedented power and insight into the hands of patients and healthcare providers.
Omar Ishrak Posterity will determine the legacy of Medtronic's CEO, Omar Ishrak, but at least he is not afraid to take risks.
Guy Neev Guy Neev is CEO of Check-Cap, an Israeli-based medical diagnostics startup that is poised to transform colorectal screening.
Andrew Thompson Andrew Thompson is co-founder, president and CEO of Proteus Digital Health, a California company that is wielding medical technology, wearable technology, wireless technology and cloud technology to solve the problem of poor medication adherence.
Virginia M. (Ginni) Rometty Virginia (Ginni) Rometty is chairman, president and CEO of IBM.
An investor from a healthcare venture capital firm discusses the best practices when pitching to investors.
See how our panel of regulatory experts rated the agency on everything from transparency and consistency to UDI implementation.
Medical device makers need to rethink their sales approaches and consider risk-based agreements if they want to compete in the new healthcare landscape.